Wachtell Lipton Guides Mallinckrodt In $1.33B Therakos Buy
Irish drugmaker Mallinckrodt PLC has agreed to acquire Therakos Inc. from buyout firm The Gores Group for $1.33 billion, the companies said Monday, adding to Mallinckrodt's portfolio an immunotherapy company that...To view the full article, register now.
Already a subscriber? Click here to view full article